| James R Heaberlin, MD | |
|
2999 N Mayfair Rd, Wauwatosa, WI 53222-4306 | |
| (414) 479-7000 | |
| (414) 479-7001 |
| Full Name | James R Heaberlin |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 9 Years |
| Location | 2999 N Mayfair Rd, Wauwatosa, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043604960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 75451 (Wisconsin) | Primary |
| 207X00000X | Orthopaedic Surgery | 75451 (Wisconsin) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
| Aurora Medical Center - Grafton | Grafton, WI | Hospital |
| West Allis Memorial Hospital | West allis, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Advanced Healthcare Inc | 3375625833 | 929 |
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Measuring the levels of small molecules in the blood may be able to identify individuals at elevated risk of developing type 2 diabetes as much as a decade before symptoms of the disorder appear.
Hastings Center Scholar Erik Parens, PhD, will speak about behavioral genetics to the Presidential Commission for the Study of Bioethical Issues on Monday, February 28. The meeting kicks off the Commission's examination of the ethical and policy issues raised by genetics and neuroscience. Topics will include the use of genetics, neuroscience, and neuroimaging for testing, research, diagnosis, risk identification, and health promotion. Parens was invited to discuss what he considers the most pressing ethical and social issues that behavioral genetics research raises.
Kaiser Health News staff writer Christopher Weaver writes about new funding available to cash-strapped states: "Starting today, states can choose to take the first steps toward the massive expansion of insurance coverage that is the health overhaul's chief goal.
› Verified 7 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Measuring the levels of small molecules in the blood may be able to identify individuals at elevated risk of developing type 2 diabetes as much as a decade before symptoms of the disorder appear.
Hastings Center Scholar Erik Parens, PhD, will speak about behavioral genetics to the Presidential Commission for the Study of Bioethical Issues on Monday, February 28. The meeting kicks off the Commission's examination of the ethical and policy issues raised by genetics and neuroscience. Topics will include the use of genetics, neuroscience, and neuroimaging for testing, research, diagnosis, risk identification, and health promotion. Parens was invited to discuss what he considers the most pressing ethical and social issues that behavioral genetics research raises.
Kaiser Health News staff writer Christopher Weaver writes about new funding available to cash-strapped states: "Starting today, states can choose to take the first steps toward the massive expansion of insurance coverage that is the health overhaul's chief goal.
› Verified 7 days ago
| Entity Name | Aurora Advanced Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Measuring the levels of small molecules in the blood may be able to identify individuals at elevated risk of developing type 2 diabetes as much as a decade before symptoms of the disorder appear.
Hastings Center Scholar Erik Parens, PhD, will speak about behavioral genetics to the Presidential Commission for the Study of Bioethical Issues on Monday, February 28. The meeting kicks off the Commission's examination of the ethical and policy issues raised by genetics and neuroscience. Topics will include the use of genetics, neuroscience, and neuroimaging for testing, research, diagnosis, risk identification, and health promotion. Parens was invited to discuss what he considers the most pressing ethical and social issues that behavioral genetics research raises.
Kaiser Health News staff writer Christopher Weaver writes about new funding available to cash-strapped states: "Starting today, states can choose to take the first steps toward the massive expansion of insurance coverage that is the health overhaul's chief goal.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James R Heaberlin, MD 2999 N Mayfair Rd, Wauwatosa, WI 53222-4306 Ph: (414) 479-7000 | James R Heaberlin, MD 2999 N Mayfair Rd, Wauwatosa, WI 53222-4306 Ph: (414) 479-7000 |
News Archive
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
Measuring the levels of small molecules in the blood may be able to identify individuals at elevated risk of developing type 2 diabetes as much as a decade before symptoms of the disorder appear.
Hastings Center Scholar Erik Parens, PhD, will speak about behavioral genetics to the Presidential Commission for the Study of Bioethical Issues on Monday, February 28. The meeting kicks off the Commission's examination of the ethical and policy issues raised by genetics and neuroscience. Topics will include the use of genetics, neuroscience, and neuroimaging for testing, research, diagnosis, risk identification, and health promotion. Parens was invited to discuss what he considers the most pressing ethical and social issues that behavioral genetics research raises.
Kaiser Health News staff writer Christopher Weaver writes about new funding available to cash-strapped states: "Starting today, states can choose to take the first steps toward the massive expansion of insurance coverage that is the health overhaul's chief goal.
› Verified 7 days ago
Thomas Joseph Parisi, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3077 N Mayfair Rd Ste 305, Wauwatosa, WI 53222 Phone: 414-384-6700 Fax: 414-727-1058 | |
Conor Patrick Mcbride, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 8701 W Watertown Plank Rd, Wauwatosa, WI 53226 Phone: 414-456-8296 | |
Sean Carroll Tracy, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N Mayfair Rd, Suite 500, Wauwatosa, WI 53226 Phone: 414-257-2525 Fax: 414-257-1772 | |
Brian A. Mccarty, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3077 N Mayfair Rd Ste 100, Wauwatosa, WI 53222 Phone: 414-384-6700 Fax: 414-727-1058 | |
Bindu S. Bamrah, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3077 N Mayfair Rd Ste 305, Wauwatosa, WI 53222 Phone: 414-384-6700 | |
David L Becker, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3289 N Mayfair Rd, Wauwatosa, WI 53222 Phone: 414-771-7900 Fax: 414-771-7249 |